Treatment of Elderly Patients With Chronic Lymphocytic Leukemia

An Unmet Clinical Need

Stefano Molica; Maura Brugiatelli; Fortunato Morabito; Felicetto Ferrara; Emilio Iannitto; Nicola Di Renzo; Silvana Capalbo; Pellegrino Musto; Francesco Di Raimondo


Expert Rev Hematol. 2013;6(4):441-449. 

In This Article

Upfront Therapeutic Options for Unfit Patients

For medically unfit CLL patients, treatment goals are the achievement of a clinical response, symptom relief and eventually prolongation of active life expectancy.[32] It is noteworthy that most of the information based on a sub-analysis of the largest clinical trials, include only 25–30% of patients above the age of 65 years and only 10% above the age of 70 years.